EP2328611A4 - Compositions et procédés destinés à traiter une infection par s. pneumoniae - Google Patents

Compositions et procédés destinés à traiter une infection par s. pneumoniae

Info

Publication number: EP2328611A4
Authority: EP; European Patent Office
Prior art keywords: compositions; treating; methods; pneumonia infection; pneumonia
Prior art date: 2008-09-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP09812778A

Other languages

German (de)

English (en)

Other versions

EP2328611A2 (fr

Inventor

Yaffa Mizrachi-Nebenzahl

Ron Dagan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ben Gurion University of the Negev Research and Development Authority Ltd

Ben Gurion University of the Negev BGU

Original Assignee

Ben Gurion University of the Negev Research and Development Authority Ltd

Ben Gurion University of the Negev BGU

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-09-11

Filing date

2009-09-10

Publication date

2011-10-12

2009-09-10 Application filed by Ben Gurion University of the Negev Research and Development Authority Ltd, Ben Gurion University of the Negev BGU filed Critical Ben Gurion University of the Negev Research and Development Authority Ltd

2011-06-08 Publication of EP2328611A2 publication Critical patent/EP2328611A2/fr

2011-10-12 Publication of EP2328611A4 publication Critical patent/EP2328611A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP09812778A 2008-09-11 2009-09-10 Compositions et procédés destinés à traiter une infection par s. pneumoniae Withdrawn EP2328611A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13651608P	2008-09-11	2008-09-11
PCT/IL2009/000883 WO2010029546A2 (fr)	2008-09-11	2009-09-10	Compositions et procédés destinés à traiter une infection par s. pneumoniae

Publications (2)

Publication Number	Publication Date
EP2328611A2 EP2328611A2 (fr)	2011-06-08
EP2328611A4 true EP2328611A4 (fr)	2011-10-12

Family

ID=42005574

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP09812778A Withdrawn EP2328611A4 (fr)	2008-09-11	2009-09-10	Compositions et procédés destinés à traiter une infection par s. pneumoniae

Country Status (3)

Country	Link
US (1)	US20120003203A1 (fr)
EP (1)	EP2328611A4 (fr)
WO (1)	WO2010029546A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201601571D0 (en) *	2016-01-28	2016-03-16	Nordic Bioscience As	Collagen type Vll alpha 1 assay

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000060082A2 (fr) *	1999-04-07	2000-10-12	Incyte Pharmaceuticals, Inc.	Proteines associees a une vesicule
CN1347897A (zh) *	2000-10-11	2002-05-08	上海博德基因开发有限公司	一种新的多肽——核糖体蛋白l2家族26.73和编码这种多肽的多核苷酸
WO2005026206A2 (fr) *	2003-09-16	2005-03-24	Ark Therapeutics Ltd.	Genes induits par le facteur de croissance endotheliale (vegf) et leur utilisation therapeutique
EP1923069A1 (fr) *	2006-11-20	2008-05-21	Intercell AG	Peptides protecteurs contre S. pneumoniae et compositions, méthodes et utilisations associés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2522238A1 (fr) *	2003-04-15	2004-10-28	Intercell Ag	Antigenes s-pneumoniae
WO2007113819A2 (fr) *	2006-03-30	2007-10-11	Ben-Gurion University Of The Negev Research And Development Authority	Méthodes et compositions destinés à prévenir et traiter une infection due au streptococcus pneumoniae
WO2008104953A2 (fr) *	2007-02-28	2008-09-04	The Procter & Gamble Company	Procédés et cibles d'identification de composés permettant la régulation d'une infection par rhinovirus

2009
- 2009-09-10 WO PCT/IL2009/000883 patent/WO2010029546A2/fr not_active Ceased
- 2009-09-10 US US13/063,318 patent/US20120003203A1/en not_active Abandoned
- 2009-09-10 EP EP09812778A patent/EP2328611A4/fr not_active Withdrawn

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000060082A2 (fr) *	1999-04-07	2000-10-12	Incyte Pharmaceuticals, Inc.	Proteines associees a une vesicule
CN1347897A (zh) *	2000-10-11	2002-05-08	上海博德基因开发有限公司	一种新的多肽——核糖体蛋白l2家族26.73和编码这种多肽的多核苷酸
WO2005026206A2 (fr) *	2003-09-16	2005-03-24	Ark Therapeutics Ltd.	Genes induits par le facteur de croissance endotheliale (vegf) et leur utilisation therapeutique
EP1923069A1 (fr) *	2006-11-20	2008-05-21	Intercell AG	Peptides protecteurs contre S. pneumoniae et compositions, méthodes et utilisations associés

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
K MORINAKA ET AL: "Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis", ONCOGENE, vol. 18, no. 43, 1 October 1999 (1999-10-01), pages 5915 - 5922, XP055005953, ISSN: 0950-9232, DOI: 10.1038/sj.onc.1202974 *
See also references of WO2010029546A2 *
WOLVERTON T ET AL: "Identification and Characterization of Three Members of a Novel Subclass of Protocadherins", GENOMICS, vol. 76, no. 1-3, 1 August 2001 (2001-08-01), pages 66 - 72, XP004459579, ISSN: 0888-7543, DOI: 10.1006/GENO.2001.6592 *

Also Published As

Publication number	Publication date
EP2328611A2 (fr)	2011-06-08
US20120003203A1 (en)	2012-01-05
WO2010029546A2 (fr)	2010-03-18
WO2010029546A3 (fr)	2010-09-02

Publication	Publication Date	Title
CY2019005I1 (el)	2019-11-27	Συνθεσεις και μεθοδοι για την αναστολη εκφρασης τρανσθυρετινης
EP2503995A4 (fr)	2014-05-21	Procédés, compositions et trousses de lyophilisation
BRPI0912046A2 (pt)	2017-06-20	composições de hibridização e métodos
EP2635254A4 (fr)	2014-11-05	Compositions et procédés visant à une réduction de la mucoadhérence
EP2651209A4 (fr)	2014-09-17	Soja comprenant le mécanisme de transformation syht04r, et compositions et procédés de détection de ce mécanisme
EP2240452A4 (fr)	2011-11-30	Entités chimiques, compositions et procédés
EP2274009A4 (fr)	2012-01-25	Procédés de traitement
EP2232367A4 (fr)	2011-03-09	Multitraitement déterministe
EP2376659A4 (fr)	2013-01-23	Procédés, compositions et nécessaires de détection de variantes alléliques
EP1868628A4 (fr)	2009-12-02	Composes, compositions et methodes de traitement des infections a poxvirus
BRPI0815841A2 (pt)	2015-09-01	Métodos e composições para melhoramento de traços preferidos.
BRPI0816170A2 (pt)	2015-02-24	Composições poliolefínicas compatibilizadas
BRPI0918652A2 (pt)	2015-08-25	Composições farmacêuticas e métodos de libração relacionadas.
DK2214679T3 (da)	2019-05-20	Kortikosteroidsammensætninger
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
EP2323628A4 (fr)	2013-07-24	Nanoparticules de support et compositions, procédés et systèmes apparentés
BRPI0918122A8 (pt)	2017-01-24	molécula de diabody, diabody, e mólecula dart
BRPI0814594A2 (pt)	2015-01-20	Composições e métodos adjuvantes de antígeno
EP2222893A4 (fr)	2014-03-26	Nouvelles compositions et procédés, revêtements et articles apparentés
EP2043696A4 (fr)	2012-01-04	Procédés et compositions de ciblage de la protéine gc1qr/p32
DK2245032T3 (da)	2015-06-22	Folater, sammensætninger og anvendelser deraf
BRPI0915900A2 (pt)	2015-10-27	composições e métodos para nutrição com silício foliarmente aplicáveis
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
BRPI0917172A2 (pt)	2015-08-04	Composição bacteriana

Legal Events

Date	Code	Title	Description
2011-05-06	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2011-06-08	17P	Request for examination filed	Effective date: 20110311
2011-06-08	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
2011-06-08	AX	Request for extension of the european patent	Extension state: AL BA RS
2011-10-12	A4	Supplementary search report drawn up and despatched	Effective date: 20110913
2011-10-12	RIC1	Information provided on ipc code assigned before grant	Ipc: C07K 7/08 20060101ALI20110907BHEP Ipc: C07K 7/06 20060101ALI20110907BHEP Ipc: A61K 38/00 20060101ALI20110907BHEP Ipc: A61K 39/09 20060101AFI20110907BHEP
2011-12-21	DAX	Request for extension of the european patent (deleted)
2013-05-01	17Q	First examination report despatched	Effective date: 20130408
2013-11-26	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2013-12-25	INTG	Intention to grant announced	Effective date: 20131127
2014-09-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2014-10-08	18D	Application deemed to be withdrawn	Effective date: 20140408